Health
South African virus mutation raises questions over vaccine effectiveness – The Times of Israel
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna…
PARIS (AFP) — As the British coronavirus variant occupies countries’ pandemic plans due to its increased transmissibility, other mutations to the Sars-CoV-2 are provoking concern among scientists who are scrambling to work out if they will respond to vaccines.
In particular, one mutation, known as E484K, detected initially in South Africa and on subsequent variants in Brazil and Japan, has raised alarm among researchers.
Ravi Gupta, professor of microbiology at the University of Cambridge, said…
-
Business15 hours agoWarning! These ASX 200 shares were just downgraded
-
Business13 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoSergio Perez and Valtteri Bottas to return to Formula 1 with Cadillac
-
Noosa News9 hours agoVegetables and herbs you can easily and cheaply grow from seeds